Development of Immuno-Enzymatic Monoclonal Tests-Systems for the Detection of Glanders and Melioidosis Agents

Objective of the study was the development of immune-enzymatic monoclonal test-kit for detecting glanders and melioidosis agents. Materials and methods. We used microbial cultures and hybrid cell lines obtained from the collection of the «48^th Central Research Institute» of the Ministry of Defense of the Russian Federation. Hybridoma cells were incubated in the peritoneal cavity of BALB/c mice. Preparations of glanders and melioidosis monoclonal antibodies were isolated from the ascetic fluids through precipitation with ammonium sulfate and purification by means of ion-exchange chromatography. Specific components of the test-kits were subjected to freeze drying in corresponding protective media. Study of diagnostic properties of the developed test systems was performed using ELISA. Results and conclusions. We have obtained preparations of monoclonal antibodies in vivo, as well as isolated and purified immunoglobulins from ascetic fluids. We also selected the pairs of monoclonal antibodies for manufacturing specific components. Experimental series of immune-enzymatic monoclonal test-systems allowing for specific detection of glanders and melioidosis causative agents in concentrations ranging from 0.5·10⁶ CFU/ml and higher were made. The absence of cross-reactivity with closely related saprophytes and heterologous microorganisms in concentrations of 1,0·10⁸ CFU/ml was shown. Demonstrated was the possibility in principle to differentiate between Burkholderia malleiand Burkholderia pseudomallei using ELISA. Test systems are promising for follow up state registration as medical products for in vitro diagnostics.

1. Ketti D, editor [Antibodies. Methods. Volume 1]. Translated from English. Moscow: “Mir”; 1991. 287 p.

2. Zamarina T.V., Khrapova N.P., Korsakova I.I., Pimenova E.V. [Designing of experimental immune-enzymatic test-system on the basis of monoclonal antibodies to melioidosis agent antigen 200 kDa]. Vestnik Volgogradskogo Gosudarstvennogo Meditsinskogo Universiteta. (Bulletin of the Volgograd State Medical University). 2014; 3:93–5.

3. Prokhvatilova E.V., Khrapova N.P. [Concerning the obtainment of luminescent monoclonal immunoglobulins for the detection of melioidosis causative agent]. In: [Ecological-epidemiological sur-veillance over natural focal infections in the Northern Caspian Sea region]. Astrakhan; 1996. P. 147–8.

4. Prokhvatilova E.V. [Concerning the development of new immune-biological preparations based on monoclonal antibodies to Burkholderia mallei and Burkholderia pseudomallei. Problemy Osobo Opasnykh Infektsii [Problems of Particularly Dangerous Infections]. 2003; 2:153–8.

5. Cheng A.C., Currie B.J. Melioidosis: epidemiology, pathophysiology and management. Clin. Microbiol. Rev. 2005; 18(2):383–416. DOI: 10.1128/CMR.18.2.383-416.2005.

6. Harvey S.P., Minter J.M. Ribotyping of Burkholderia malleiisolates.FEMS Immunol. Med. Microbiol.2005. 44(1):91–7. DOI: 10.1016/j.femsim.2004.12.002.

7. Khrapova N.P., Tikhonov N.G., Prokhvatilova Y.V. Detection of Glycoprotein of Burkholderia pseudomallei. Emerg. Infect. Dis. 1998; 4(2):336–7. DOI: 10.3201/eid0402.980229.

8. Nakane P.K., Kawaoi A. Peroxidase-labeled antibody. A new method of conjugated J. Histochem. Cytochem. 1974; 22(12):1084–91. DOI: 10.1177/22.12.1084.

9. Sudhir K. Dohre, Urmil Tuteja, Subodh Kumar Generation and Characterization of Monoclonal Antibodies Specific to Burkholderia mallei. Int. J. Curr. Microbiol. App. Sci. 2016; 5(5):342–9. DOI: 10.20546/ijcmas.2016.505.035.

10. Woods K.L., Boutthasavong L., NicFhogartaigh C., Lee S.J., Davong V., AuCoin D.P., Dance D.A.B. Evaluation of a rapid diagnostic test for detection of Burkholderia pseudomallei in the Lao People’s Democratic Republic. J. Clin. Microbiol. 2018; 56(7):e02002–17. DOI: 10.1128/jcm.02002-17.

11. Zhang S., Feng S.H., Li B., Kim H.Y., Rodriguez J., Tsai S, Lo S.C. In vitroand in vivostudies of monoclonal antibodies with prominent bactericidal activity against Burkholderia pseudomallei andBurkholderia mallei. Clin. Vaccine Immunol. 2011; 18(5):825–34. DOI: 10.1128/CVI.00533-10.